Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis
Betamethason Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis
Sponsor: OrthoCarolina Research Institute, Inc.
This PHASE4 trial investigates DeQuervain Tendinopathy and is currently completed. OrthoCarolina Research Institute, Inc. leads this study, which shows 16 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
16 versions recorded-
May 2025 — Present [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
-
Mar 2023 — May 2024 [monthly]
Active Not Recruiting PHASE4
▶ Show 11 earlier versions
-
Sep 2022 — Mar 2023 [monthly]
Active Not Recruiting PHASE4
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE4
-
Feb 2021 — Jul 2022 [monthly]
Active Not Recruiting PHASE4
Status: Enrolling By Invitation → Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE4
Status: Recruiting → Enrolling By Invitation
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Aug 2019 — Oct 2020 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- OrthoCarolina Research Institute, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .